Plasmacytoma of the testis in a patient with relapsed and refractory multiple myeloma: Case report and review of the literature

by Munad Khan, Nieroshan Rajarubendra, Sarah Azer, Alison Skene, Simon J Harrison, Belinda Campbell, Nathan Lawrentschuk
Published 2015-01-01

The Use of Optimal Treatment for DLBCL Is Improving in All Age Groups and Is a Key Factor in Overall Survival, but Non-Clinical Factors Influence Treatment

by Nicole Wong Doo, Victoria M. White, Kara Martin, Julie K. Bassett, H. Miles Prince, Simon J. Harrison, Michael Jefford, Ingrid Winship, Jeremy L. Millar, Roger L. Milne, John F. Seymour, Graham G. Giles
Published 2019-07-01

Predicting Risk of Infection in Patients with Newly Diagnosed Multiple Myeloma: Utility of Immune Profiling

by Benjamin W. Teh, Benjamin W. Teh, Benjamin W. Teh, Benjamin W. Teh, Simon J. Harrison, Simon J. Harrison, Cody Charles Allison, Monica A. Slavin, Monica A. Slavin, Monica A. Slavin, Monica A. Slavin, Monica A. Slavin, Tim Spelman, Tim Spelman, Leon J. Worth, Leon J. Worth, Leon J. Worth, Karin A. Thursky, Karin A. Thursky, Karin A. Thursky, Karin A. Thursky, Karin A. Thursky, David Ritchie, David Ritchie, Marc Pellegrini, Marc Pellegrini, Marc Pellegrini
Published 2017-10-01

CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy

by Lauren Giuffrida, Kevin Sek, Melissa A. Henderson, Junyun Lai, Amanda X. Y. Chen, Deborah Meyran, Kirsten L. Todd, Emma V. Petley, Sherly Mardiana, Christina Mølck, Gregory D. Stewart, Benjamin J. Solomon, Ian A. Parish, Paul J. Neeson, Simon J. Harrison, Lev M. Kats, Imran G. House, Phillip K. Darcy, Paul A. Beavis
Published 2021-05-01